Matches in Wikidata for { <http://www.wikidata.org/entity/Q64187021> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64187021 description "clinical trial" @default.
- Q64187021 description "ensayu clínicu" @default.
- Q64187021 description "klinisch onderzoek" @default.
- Q64187021 description "клінічне випробування" @default.
- Q64187021 name "A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)" @default.
- Q64187021 type Item @default.
- Q64187021 label "A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)" @default.
- Q64187021 prefLabel "A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)" @default.
- Q64187021 P1132 Q64187021-934E9D25-9F6A-4886-8DFD-0D95C2C4079C @default.
- Q64187021 P1476 Q64187021-13C37418-5ABB-4909-9B88-1AE7E95EE5C1 @default.
- Q64187021 P17 Q64187021-04BCE4F7-E0D2-439A-8FE4-BC8613A91C97 @default.
- Q64187021 P17 Q64187021-0693B6FB-EC55-400B-99D9-17E8AE362535 @default.
- Q64187021 P17 Q64187021-0D48854A-4ADB-4E33-9FF3-A28CA6AF504D @default.
- Q64187021 P17 Q64187021-0DD843C7-8012-4A23-9786-00CD4EE45D43 @default.
- Q64187021 P17 Q64187021-433A9AE7-088D-45B1-9B5B-B53CA0414B71 @default.
- Q64187021 P17 Q64187021-4345D917-B9E1-4B45-AF70-A5AA01F710F6 @default.
- Q64187021 P17 Q64187021-95FEE6B8-A486-464D-AB99-677F668211A6 @default.
- Q64187021 P17 Q64187021-9B572EBE-C200-4B77-A472-DFB7D7D04D58 @default.
- Q64187021 P17 Q64187021-B49BF2A1-F94C-4EAB-B282-BC7C165DCA96 @default.
- Q64187021 P17 Q64187021-DEE4D6FD-5695-4B78-8ED3-3CC9CC4DC157 @default.
- Q64187021 P17 Q64187021-F5508774-CE39-4D4D-9A78-33798C63D06F @default.
- Q64187021 P17 Q64187021-F699C042-5734-4A14-999B-BF2B70F3FD43 @default.
- Q64187021 P17 Q64187021-FA6D7680-3F7D-49CD-84A6-B1D59891A67F @default.
- Q64187021 P2899 Q64187021-EA0E8C0D-62E3-42BA-8E56-5AB696E06725 @default.
- Q64187021 P3098 Q64187021-478C829A-4D86-4422-819E-47BC3D355FE3 @default.
- Q64187021 P31 Q64187021-60DB9155-B63F-454D-8739-3CFC7DEB8ACA @default.
- Q64187021 P4135 Q64187021-E1791E18-83B2-496F-8C40-2422632033BF @default.
- Q64187021 P580 Q64187021-436226F4-A40E-43D2-B98C-FA87B89C74D3 @default.
- Q64187021 P582 Q64187021-72FC2D53-DCAF-4372-9E24-5F09114F1620 @default.
- Q64187021 P6099 Q64187021-954386E8-BEA7-4404-ACEE-21EDB6131265 @default.
- Q64187021 P8363 Q64187021-BFAFF9F5-4942-4306-9D9C-8D9FBFD4A732 @default.
- Q64187021 P921 Q64187021-47B36BBA-5706-45B1-A667-1B5F0530CC33 @default.
- Q64187021 P1132 "+161" @default.
- Q64187021 P1476 "A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)" @default.
- Q64187021 P17 Q184 @default.
- Q64187021 P17 Q212 @default.
- Q64187021 P17 Q218 @default.
- Q64187021 P17 Q219 @default.
- Q64187021 P17 Q230 @default.
- Q64187021 P17 Q30 @default.
- Q64187021 P17 Q36 @default.
- Q64187021 P17 Q38 @default.
- Q64187021 P17 Q399 @default.
- Q64187021 P17 Q408 @default.
- Q64187021 P17 Q41 @default.
- Q64187021 P17 Q43 @default.
- Q64187021 P17 Q664 @default.
- Q64187021 P2899 "+3" @default.
- Q64187021 P3098 "NCT02781727" @default.
- Q64187021 P31 Q30612 @default.
- Q64187021 P4135 "+12" @default.
- Q64187021 P580 "2016-12-13T00:00:00Z" @default.
- Q64187021 P582 "2019-01-17T00:00:00Z" @default.
- Q64187021 P6099 Q42824827 @default.
- Q64187021 P8363 Q78089383 @default.
- Q64187021 P921 Q58526200 @default.